课题基金 / 基金详情

PATHOPHYSIOLOGY OF CUTANEOUS VASCULAR LESIONS

PATHOPHYSIOLOGY OF CUTANEOUS VASCULAR LESIONS
皮肤血管病变的病理生理学
批准号:
6532911
负责人:
JACK L ARBISER
金额:
$10.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-15 至 2004-08-31

项目摘要

项目成果

JACK L ARBISER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This Career Development Award Proposal focuses on the pathogenesis of cutaneous vascular lesions. Hemangiomas are the most common cutaneous vascular lesions of childhood, and are present in 10 percent of infants at 1 year of age. These hemangiomas may grow to large size, resulting in compression of vital structures, high output cardiac failure, and coagulopathy. The coagulopathy phenomenon is known as the Kasabach- Merritt syndrome. Treatment of large hemangiomas requires lengthy treatment with steroids or alpha interferon, and surgery. A significant number of these hemangiomas do not respond to treatment, resulting in death. Little is known of the pathophysiology of these lesions, but preliminary evidence points to an imbalance of angiogenesis stimulators and inhibitors. We have developed a murine model of proliferative vascular lesions through the sequential introduction of SV40 large T antigen and H-ras into endothelial cells. This model recapitulates clinical and histologic features of both nonproliferative and proliferative hemangiomas. I wish to study the signal transduction pathways involved in upregulation of angiogenesis stimulators and downregulation of angiogenesis inhibitors. In addition, I have found that transformed endothelial cells express both VEGF and its receptor, flk-1, suggesting a possible autocrine loop. Finally, the novel angiogenesis inhibitor endostatin has been isolated from a spontaneous hemangioendothelioma cell line. Its mechanism of action is unknown. I hope to learn the signal transduction pathways through which endostatin mediates angiogenesis inhibition. Interruption of angiogenic autocrine loops and targeting of signal transduction pathways activated in proliferative vascular lesions may provide novel therapies for hemangiomas. The Folkman laboratory has extensive experience in the isolation and characterization of angiogenesis stimulators and inhibitors. In order to become an independent investigator in angiogenesis, proficiency in these techniques is necessary. The opportunity to carry out the studies outlined in this proposal and receive formal training in cell biology, protein purification and characterization, and surgical procedures will afford the applicant the training which is required toward the establishment of his career as an independent physician-scientist.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Regulation of angiogenesis and tumorigenesis by signal transduction cascades: lessons from benign and malignant endothelial tumors.
通过信号转导级联调节血管生成和肿瘤发生:良性和恶性内皮肿瘤的教训。
DOI: 10.1046/j.1087-0024.2000.00007.x
发表时间: 2000
期刊: The journal of investigative dermatology. Symposium proceedings
影响因子: --
作者: [Klafter,R, Arbiser,JL]
通讯作者: Arbiser,JL
Ceramide Analog Control of Cutaneous Inflammation
  • 批准号:
    10368633
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    JACK L ARBISER
  • 依托单位:
Palladium based nanoparticles for the treatment of advanced melanoma
  • 批准号:
    9206894
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    JACK L ARBISER
  • 依托单位:
Skin Manifestations of Tuberous Sclerosis
  • 批准号:
    7674820
  • 项目类别:
  • 资助金额:
    $21.89万
  • 财政年份:
    2005
  • 负责人:
    JACK L ARBISER
  • 依托单位:
Skin Manifestations of Tuberous Sclerosis
  • 批准号:
    7483282
  • 项目类别:
  • 资助金额:
    $21.89万
  • 财政年份:
    2005
  • 负责人:
    JACK L ARBISER
  • 依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
  • 批准号:
    81200692
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    陈凌
  • 依托单位: